miltefosine has been researched along with carbonyl cyanide m-chlorophenyl hydrazone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chandrakar, P; Gupta, S; Kar, S; Kushwaha, P; Parmar, N; Rashid, M; Sashidhara, KV; Singh, SK; Upadhyay, A; Wahajuddin, M | 1 |
| Chandrakar, P; Gunaganti, N; Kar, S; Kumar, A; Mitra, K; Narender, T; Parmar, N; Rashid, M; Singh, SK; Wahajuddin, M | 1 |
| Chandrakar, P; Goel, A; Kar, S; Mishra, S; Parmar, N; Parveen, S; Seth, A; Sharma, CP; Vats, RP | 1 |
3 other study(ies) available for miltefosine and carbonyl cyanide m-chlorophenyl hydrazone
| Article | Year |
|---|---|
Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Disease Models, Animal; Leishmania donovani; Leishmaniasis, Visceral; Metronidazole; Quinolines; Rats; Structure-Activity Relationship; Tissue Distribution; Vero Cells | 2019 |
β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.
Topics: Amino Acids; Animals; Antiprotozoal Agents; Cell Survival; Chlorocebus aethiops; Cricetinae; Dose-Response Relationship, Drug; Electron Transport Complex III; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Mitochondria; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Vero Cells | 2019 |
Design, synthesis, in vitro and in vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Leishmania donovani; Mice; Molecular Structure; Parasitic Sensitivity Tests; Piperazine; Pyridones; Structure-Activity Relationship | 2021 |